OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Sinus Pain reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,277 reports · 102 co-occurring drugs

As of the last recalculation, Sinus Pain appears in 2,277 FAERS reports alongside 102 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 72.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ciclesonide10372.472.9
Diltiazem Hydrochloride Extended-Release Tablets3226.126.1
Mometasone5025.525.5
Theophylline3125.025.0
Theophylline Anhydrous3223.924.0
Omalizumab20323.823.9
Mometasone Furoate10323.623.7
Fluticasone Propionate And Salmeterol Xinafoate12620.220.3
Diphenhydramine Hydrochloride Capsule, Liquid Filled4620.120.1
Ipratropium Bromide7018.518.5
Fluticasone Furoate And Vilanterol Trifenatate6617.217.3
Hydrocortisone Sodium Succinate1716.616.7
Infliximab-Dyyb5216.616.6
Dimenhydrinate1916.416.5
Cenegermin-Bkbj2116.016.0
Rosuvastatin Calcium4815.915.9
Elexacaftor, Tezacaftor, And Ivacaftor2115.515.6
Zinc4115.515.5
Zinc Chloride4115.415.4
Fluticasone Furoate2015.215.2
Zinc Gluconate4114.614.6
Lifitegrast2514.114.2
Moxifloxacin2113.713.8
Mepolizumab7013.313.3
Pramipexole2112.612.6
Moxifloxacin Hydrochloride2310.510.5
Albuterol Sulfate29410.210.3
Azithromycin4410.210.2
Budesonide And Formoterol Fumarate Dihydrate10310.110.1
Metformin Hydrochloride Tablets6110.010.0
Metformin Hydrochloride Extended-Release Tablets6110.010.0
Metformin Hydrochloride Tablet6110.010.0
Rizatriptan Benzoate119.99.9
Human Immunoglobulin G229.89.8
Azithromycin Monohydrate449.89.8
Metformin Hydrochloride619.79.7
Diltiazem Hydrochloride369.69.7
Iron669.39.3
Cetirizine Hydrochloride Allergy309.29.2
Cetirizine Hydrochloride Tablets309.29.2
Albuterol1139.09.0
Nitrofurantoin168.98.9
Nitrofurantoin (Monohydrate/Macrocrystals)168.88.8
Azelastine178.78.7
Cephalexin208.58.5
Nirmatrelvir And Ritonavir488.38.3
Montelukast Sodium1058.28.2
Doxepin98.18.2
Atorvastatin Calcium, Film Coated618.18.1
Azithromycin Dihydrate518.18.1
Hyoscyamine Sulfate88.08.0
Fluticasone Propionate Nasal267.97.9
Carboxymethylcellulose Sodium87.87.8
Desoximetasone167.77.7
Epoprostenol117.77.7
Fluticasone Propionate1057.77.7
Levocetirizine Dihydrochloride207.77.7
Crisaborole87.67.6
Baricitinib87.67.6
Botulinum Toxin Type A107.47.4
Oxybutynin Chloride77.37.3
Thiamine Hydrochloride, Riboflavin 5 Phosphate Sodium, Dexpanthenol And Niacinamide247.37.3
Cetirizine Hcl77.07.0
Tiotropium Bromide976.76.7
Loratadine Tablet386.66.6
Montelukast566.26.2
Cetirizine516.16.1
Dexlansoprazole276.06.0
Piperacillin Sodium,Tazobactam Sodium175.95.9
Naproxen Sodium, Dextromethorphan Hydrobromide, Guaifenesin135.85.8
Naproxen Sodium, Pseudoephedrine Hydrochloride135.85.8
Acetaminophen, Chlorpheniramine Maleate, Phenylephrine Hcl315.75.7
Dornase Alfa125.65.6
Fremanezumab-Vfrm75.65.6
Epinephrine395.55.5
Umeclidinium Bromide And Vilanterol Trifenatate105.55.5
Ixazomib175.45.4
Selexipag155.35.3
Budesonide, Glycopyrrolate, And Formoterol Fumarate65.35.3
Siponimod55.15.1
Rimegepant Sulfate75.15.1
Riociguat174.84.8
Triamcinolone Acetonide164.84.8
Inclisiran44.64.6
Sarilumab134.54.5
Alirocumab124.44.4
Acetaminophen, Aspirin, And Caffeine104.44.4
Lisdexamfetamine Dimesylate154.24.2
Mometasone Furoate And Formoterol Fumarate Dihydrate74.14.1
Ofatumumab143.93.9
Niraparib93.73.7
Asfotase Alfa43.73.7
Treprostinil493.63.6
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate143.13.1
Eptinezumab-Jjmr33.03.0
Benralizumab62.72.7
Dupilumab1192.32.3
Ambrisentan312.32.3
Abaloparatide72.22.2
Erenumab-Aooe122.02.0
Evolocumab311.81.8
Esketamine Hydrochloride31.51.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.